Advagene Biopharma Co., Ltd. (6709.TWO)
TWD 18.45
(2.5%)
TWD 18.45
(2.5%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 147.93 Million TWD | 5.04% |
| 2022 | 140.83 Million TWD | -45.92% |
| 2021 | 260.4 Million TWD | -17.66% |
| 2020 | 316.25 Million TWD | 13.26% |
| 2019 | 279.21 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 126.5 Million TWD | -14.49% |
| 2024 Q2 | 126.5 Million TWD | 0.0% |
| 2023 FY | 147.93 Million TWD | 5.04% |
| 2023 Q2 | 93.9 Million TWD | 0.0% |
| 2023 Q1 | 93.9 Million TWD | -33.32% |
| 2023 Q3 | 147.93 Million TWD | 57.54% |
| 2023 Q4 | 147.93 Million TWD | 0.0% |
| 2022 Q3 | 140.83 Million TWD | 0.0% |
| 2022 Q4 | 140.83 Million TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 94.9% |
| Level Biotechnology Inc. | 822.67 Million TWD | 82.018% |
| Sagittarius Life Science Corp | 664.72 Million TWD | 77.745% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | 73.042% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 96.201% |
| GlycoNex Incorporation | 1.55 Billion TWD | 90.473% |
| VBI | 452.1 Million TWD | 67.279% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 87.422% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | 80.238% |
| Visgeneer Inc. | 397.17 Million TWD | 62.754% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 96.076% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 93.148% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | 83.248% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 97.572% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -101.112% |
| Enimmune corporation | 604.82 Million TWD | 75.541% |
| TaiRx, Inc. | 833.74 Million TWD | 82.257% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 95.206% |
| EirGenix Inc. | 11.16 Billion TWD | 98.675% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | 74.189% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 91.361% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 95.887% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | 85.917% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | 50.858% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | 44.104% |
| Lukas Biomedical Inc. | 441.19 Million TWD | 66.469% |
| RBC Bioscience Corporation | 753.79 Million TWD | 80.375% |
| BiOptic Inc. | 613.77 Million TWD | 75.898% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 91.683% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 87.244% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | 77.059% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 95.238% |
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -15.531% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | 60.901% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 86.953% |
| Neith Corporation | 192.15 Million TWD | 23.012% |
| NaviFUS Corp. | 490.53 Million TWD | 69.842% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 87.931% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 89.149% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | 72.043% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 87.262% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 91.068% |
| AP Biosciences Inc | 890.75 Million TWD | 83.392% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 98.265% |
| 3D Global Biotech Inc. | 324.14 Million TWD | 54.362% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 88.908% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 94.543% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 99.037% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | 63.941% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | 62.723% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 92.874% |
| TCI GENE Inc. | 1.16 Billion TWD | 87.312% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | 49.782% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 89.149% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | 84.292% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | 78.82% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 96.259% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 96.13% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 87.971% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 97.36% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | 86.07% |
| Acepodia, Inc. | 6.81 Billion TWD | 97.83% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 96.134% |